• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β受体阻滞剂的副作用及禁忌证

Side effects and contraindications of beta-receptor blocking agents.

作者信息

Lydtin H

出版信息

Klin Wochenschr. 1977 May 1;55(9):415-22. doi: 10.1007/BF01488578.

DOI:10.1007/BF01488578
PMID:17766
Abstract

Unwanted effects of beta-receptor blocking agents can be divided into three categories: 1. Those arising specifically from the pharmacologic, i.e., beta-blocking action. 2. Side effects not directly (or not with certainty) related to beta-blockade. 3. Adverse and potentially specific reactions to individual beta-blocking agents. Category 1 covers the majority of adverse effects (heart failure, severe bradycardia and hypotension, arterial insufficiency, increased airways resistance, gastrointestinal symptoms, hypoglycemia). These can largely be avoided by proper selection and preparation of patients. Category 2 covers cutaneous reactions (rashes, alopecia, pruritus), purpura (thrombocytopenic and nonthrombocytopenic) etc. as well as side effects attributable to the central nervous system (antianxiety effects, nightmares etc.). In the third category the "oculo-cutaneous syndrome" associated with practolol is discussed.

摘要

β受体阻滞剂的不良反应可分为三类:1. specifically源于药理学作用,即β阻断作用的不良反应。2. 与β阻断无直接(或不确定)关联的副作用。3. 对个别β受体阻滞剂的不良及潜在特异性反应。第一类涵盖了大多数不良反应(心力衰竭、严重心动过缓和低血压、动脉供血不足、气道阻力增加、胃肠道症状、低血糖)。通过对患者进行适当的选择和准备,这些不良反应在很大程度上是可以避免的。第二类包括皮肤反应(皮疹、脱发、瘙痒)、紫癜(血小板减少性和非血小板减少性)等以及归因于中枢神经系统的副作用(抗焦虑作用、噩梦等)。在第三类中,讨论了与心得宁相关的“眼皮肤综合征”。

相似文献

1
Side effects and contraindications of beta-receptor blocking agents.β受体阻滞剂的副作用及禁忌证
Klin Wochenschr. 1977 May 1;55(9):415-22. doi: 10.1007/BF01488578.
2
Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.β-肾上腺素受体阻断药:不良反应与药物相互作用
Pharmacol Ther. 1983;21(3):351-69. doi: 10.1016/0163-7258(83)90060-8.
3
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
Am Heart J. 1979 Aug;98(2):256-62. doi: 10.1016/0002-8703(79)90229-1.
4
Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.β-肾上腺素能受体阻断药物的不良反应:来自波士顿药物监测协作计划的报告。
Drugs. 1974;7(1):118-29. doi: 10.2165/00003495-197407010-00008.
5
[Adrenergic beta receptor blockaders].
Tidsskr Nor Laegeforen. 1975 Feb 28;95(6):380-3.
6
Problems with practolol.心得宁的问题。
Drugs. 1975;10(5-6):336-41. doi: 10.2165/00003495-197510050-00003.
7
Beta-adrenergic receptor blockers. Adverse effects and drug interactions.
Hypertension. 1988 Mar;11(3 Pt 2):II21-9. doi: 10.1161/01.hyp.11.3_pt_2.ii21.
8
[Drug eruptions caused by beta-blockers].
Ann Med Interne (Paris). 1984;135(8):639-41.
9
[Therapy with beta-blocking-agents (author's transl)].β受体阻滞剂治疗(作者译)
MMW Munch Med Wochenschr. 1978 Nov 3;120(44):1461-6.
10
Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?β-肾上腺素能受体阻断药物与部分激动剂活性。这在临床上有相关性吗?
Drugs. 1983 Apr;25(4):331-8. doi: 10.2165/00003495-198325040-00001.

引用本文的文献

1
New-Onset Atrial Fibrillation in the Critically Ill COVID-19 Patients Hospitalized in the Intensive Care Unit.入住重症监护病房的危重症COVID-19患者新发房颤
J Clin Med. 2023 Nov 8;12(22):6989. doi: 10.3390/jcm12226989.
2
COVID-19 infection and cardiac arrhythmias.COVID-19 感染与心律失常。
Trends Cardiovasc Med. 2020 Nov;30(8):451-460. doi: 10.1016/j.tcm.2020.08.002. Epub 2020 Aug 16.
3
Polyunsaturated fatty acid-derived I channel activators shorten the QT interval ex-vivo and in-vivo.多不饱和脂肪酸衍生的 I 型通道激活剂可缩短离体和体内的 QT 间期。

本文引用的文献

1
Propranolol on tests of visual function and central nervous activity.普萘洛尔对视觉功能和中枢神经活动的影响
Br J Clin Pharmacol. 1974 Feb;1(1):82-4. doi: 10.1111/j.1365-2125.1974.tb00212.x.
2
CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE.充血性心力衰竭时去甲肾上腺素的儿茶酚胺排泄及心脏储备
Am J Med. 1965 Sep;39:442-51. doi: 10.1016/0002-9343(65)90211-1.
3
CARDIAC NOREPHINEPHRINE STORES IN EXPERIMENTAL HEART FAILURE IN THE DOG.犬实验性心力衰竭时心脏去甲肾上腺素的储存情况
Acta Physiol (Oxf). 2020 Aug;229(4):e13471. doi: 10.1111/apha.13471. Epub 2020 Apr 11.
J Clin Invest. 1964 Dec;43(12):2386-93. doi: 10.1172/JCI105113.
4
SERUM-TRANSAMINASE LEVELS IN PATIENTS TREATED WITH PROPRANOLOL.
Lancet. 1964 Dec 19;2(7373):1338-9. doi: 10.1016/s0140-6736(64)91127-4.
5
Effect of beta-adrenergic blockade on resting and stimulated fat mobilization.β-肾上腺素能阻断对静息和刺激状态下脂肪动员的影响。
J Clin Endocrinol Metab. 1967 Oct;27(10):1441-50. doi: 10.1210/jcem-27-10-1441.
6
The bronchoconstrictor action of propranolol aerosol in the guinea-pig.
J Physiol. 1967 May;190(2):41P-42P.
7
The bronchoconstrictor action of propranolol aerosol in asthmatic subjects.
J Physiol. 1967 May;190(2):41P.
8
Interaction of beta-receptor blocking agents with the nerve blocking effects of procaine in vitro.β受体阻滞剂与普鲁卡因体外神经阻滞作用的相互影响。
Life Sci. 1967 May 1;6(9):975-9. doi: 10.1016/0024-3205(67)90084-7.
9
[Inhibition of eosinophil decrease after adrenaline by a adrenergic beta-receptor].[肾上腺素能β受体对肾上腺素后嗜酸性粒细胞减少的抑制作用]
Klin Wochenschr. 1967 Jan 1;45(1):48-9. doi: 10.1007/BF01745740.
10
Adrenergic beta-blockade and physical working capacity.
Acta Med Scand. 1967 Jul;182(1):119-27. doi: 10.1111/j.0954-6820.1967.tb11505.x.